Pure Global

INNO-LIA ANA UPDATE - COFEPRIS Registration 1492R2021 SSA

Access comprehensive regulatory information for INNO-LIA ANA UPDATE (INNO-LIA ANA UPDATE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1492R2021 SSA and manufactured by ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.. The device was registered on September 27, 2021.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
1492R2021 SSA
INNO-LIA ANA UPDATE
COFEPRIS Analysis ID: 1492R2021 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

INNO-LIA ANA UPDATE ES UNINMUNOENSAYO DE LÍNEA PARA LADETECCIÓN E IDENTIFICACIÓN DE TRECEANTICUERPOS ANTINUCLEARES (ANA) EN ELSUERO HUMANO PARA AYUDAR EN ELDIAGNÓSTICO DE TRASTORNOS DEL TEJIDOCONECTIVO.

English

INNO-LIA ANA UPDATE IS A LINE-LINE IMMUNOASSAY FOR THE DETECTION AND IDENTIFICATION OF THIRTEEN ANTINUCLEAR ANTIBODIES (ANA) IN HUMAN SERUM TO AID IN THE DIAGNOSIS OF CONNECTIVE TISSUE DISORDERS.

Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. AGENTES DE DIAGNÓSTICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
INMUNOENSAYO PARA LA DETECCIÓN EIDENTIFICACIÓN DE TRECE ANTICUERPOSANTINUCLEARES (ANA)
Trade Name (English)
IMMUNOASSAY FOR THE DETECTION AND IDENTIFICATION OF THIRTEEN ANTIBODIESANTINUCLEAR (ANA)
Registration Information
Analysis ID
1492R2021 SSA
Registration Date
September 27, 2021
Manufacturer / Fabricante
Name (English)
ASESORES MÉDICOBIOLÓGICOS, S.A. DEC.V.